Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET studyJames S. Rakshi, David J. Brooks, Karl Friston et al.|Brain|1999Cited by 271
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18 F-dopa PET studyJames S. Rakshi, David J. Brooks, Nicola Pavese et al.|Journal of Neural Transmission|2002Cited by 59
Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's diseaseKengo Ito, David J. Brooks, Paul Morrish et al.|Journal of Neurology Neurosurgery & Psychiatry|1999Cited by 59
Methodology for Statistical Parametric Mapping of [ 18 F]Fluorodopa Uptake Rate Using Three-Dimensional PET 1 1Transcripts of the BRAINPET97 discussion of this chapter can be found in Section VIII.James S. Rakshi, David J. Brooks, John Ashburner et al.|Elsevier eBooks|1998Cited by 5